Applied Therapeutics shares surge 13.30% intraday after positive update following FDA meeting and recent leadership changes.

Tuesday, Nov 18, 2025 10:13 am ET1min read
Applied Therapeutics (APLT) surged 13.30% intraday following positive developments in its regulatory and clinical progress. Recent news highlighted a meeting with the FDA, which could reshape its rare disease pipeline, and the presentation of full 12-month clinical results from the INSPIRE Phase 2/3 trial of govorestat for.

Comments



Add a public comment...
No comments

No comments yet